Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CABOZANTINIB S-MALATE Cause Nerve compression? 16 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Nerve compression have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 0.0% of all adverse event reports for CABOZANTINIB S-MALATE.

16
Reports of Nerve compression with CABOZANTINIB S-MALATE
0.0%
of all CABOZANTINIB S-MALATE reports
0
Deaths
8
Hospitalizations

How Dangerous Is Nerve compression From CABOZANTINIB S-MALATE?

Of the 16 reports, 8 (50.0%) required hospitalization.

Is Nerve compression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CABOZANTINIB S-MALATE. However, 16 reports have been filed with the FAERS database.

What Other Side Effects Does CABOZANTINIB S-MALATE Cause?

Diarrhoea (8,282) Fatigue (6,819) Off label use (5,245) Nausea (4,341) Decreased appetite (4,076) Blood pressure increased (2,939) Malignant neoplasm progression (2,718) Palmar-plantar erythrodysaesthesia syndrome (2,706) Weight decreased (2,657) Stomatitis (2,560)

What Other Drugs Cause Nerve compression?

ADALIMUMAB (1,181) ETANERCEPT (263) TOFACITINIB (238) SODIUM OXYBATE (175) UPADACITINIB (162) RITUXIMAB (155) PREGABALIN (152) DUPILUMAB (139) PREDNISONE (137) LENALIDOMIDE (131)

Which CABOZANTINIB S-MALATE Alternatives Have Lower Nerve compression Risk?

CABOZANTINIB S-MALATE vs CAFFEINE CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL CABOZANTINIB S-MALATE vs CALCIFEDIOL CABOZANTINIB S-MALATE vs CALCIPOTRIENE

Related Pages

CABOZANTINIB S-MALATE Full Profile All Nerve compression Reports All Drugs Causing Nerve compression CABOZANTINIB S-MALATE Demographics